Simcere Pharmaceutical Group Limited: all 80 studies
Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- A Study of SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07660432Phase 1
- SIM0613 in Participants With Advanced Solid TumorsRecruitingNCT07618260Phase 1
- A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal CancerRecruitingNCT07361003Phase 3
- An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult ParticipantsRecruitingNCT07357610Phase 1
- First in Human Study of SIM0610 in Solid TumorsRecruitingNCT07348211Phase 1
- A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid TumorsRecruitingNCT07265921Phase 1
- A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic DermatitisNot yet recruitingNCT07175233Phase 2
- A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid TumorsRecruitingNCT07050459Phase 1
- A Phase I Study of SIM0388 in Participants With Malignant Ascites.RecruitingNCT07007988Phase 1
- Study of SIM0508 Alone and in Combination in Patients With Advanced Solid TumorsRecruitingNCT06686745Phase 1
- Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT06375044Phase 1
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBCRecruitingNCT06186414Phase 1
- A Phase I Trial of SIM1811-03 in Subjects With Advanced TumorsRecruitingNCT05781386Phase 1
- A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant TumorsRecruitingNCT05528055Phase 1
- Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer PatientsCompletedNCT04902885Phase 3Results posted
- A Phase III, Randomized, Double-blind, Multi-center Trial Comparing Efficacy and Safety of Trilaciclib Versus Placebo in Participants With Limited-stage Small Cell Lung CancerActive, not recruitingNCT07881705Phase 3
- A Phase I Study of SIM0532 in Adult Participants With Advanced Solid TumorsActive, not recruitingNCT07749703Phase 1
- A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult ParticipantsCompletedNCT07345364Phase 1
- A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)Active, not recruitingNCT06680921Phase 3
- Mass Balance Clinical Trial of SIM0270Active, not recruitingNCT06654791Phase 1
- Evaluate the Effects of Food on the Pharmacokinetics of SIM0270CompletedNCT06536036Phase 1
- Study of SIM0501 Alone and in Combination in Patients With Advanced Solid TumorsTerminatedNCT06331559Phase 1
- Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy SubjectsCompletedNCT06326723Phase 1
- To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy SubjectsCompletedNCT06022354Phase 1
- A Study of Daridorexant in Chinese Patients With Insomnia DisorderCompletedNCT06010693Phase 3
- Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly SubjectsStatus unknownNCT05826249Phase 1
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid TumorsTerminatedNCT05781360Phase 1
- Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With RitonavirStatus unknownNCT05731804Phase 1
- Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid TumorsTerminatedNCT05718219Phase 1
- Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy ParticipantsCompletedNCT05665647Phase 1
- A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell LymphomaStatus unknownNCT05569057Phase 1
- A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19CompletedNCT05506176Phase 2/3
- Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male ParticipantsCompletedNCT05475834Phase 1
- Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical StudyStatus unknownNCT05373446Phase 2
- To Evaluate SSD8432/Ritonavir in Adults With COVID-19Status unknownNCT05373433Phase 2/3
- To Evaluate SSD8432/ Ritonavir in Adults With COVID-19CompletedNCT05369676Phase 1/2
- A Phase I Clinical Study of SSD8432 in Healthy Adult SubjectsStatus unknownNCT05339646Phase 1
- Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT05293964Phase 1
- A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid TumorsStatus unknownNCT05254665Phase 2
- The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese VolunteersCompletedNCT05200728Phase 1
- A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid TumorsTerminatedNCT05148195Phase 2
- Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world StudyCompletedNCT05071703Phase 4
- PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based ChemotherapyStatus unknownNCT04942301Phase 1
- A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural EffusionsActive, not recruitingNCT04914598Phase 3
- A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian CancerCompletedNCT04908787Phase 3
- A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.Status unknownNCT04830644Phase 2
- An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations.TerminatedNCT04671849Phase 1
- A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid TumorsStatus unknownNCT04413227Phase 1
- A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.Status unknownNCT03763123Phase 1
- A Pilot Bioequivalence Study of PomalidomideCompletedNCT03424928Phase 1
- Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple MyelomaStatus unknownNCT02916420Phase 3
- Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered SubcutaneouslyStatus unknownNCT02805010Phase 1
- A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateStatus unknownNCT02722694Phase 3
- Study of Endostar Subcutaneous Injection in NSCLCStatus unknownNCT02652234Phase 1
- Study of Metatinib Tromethamine TabletStatus unknownNCT02650375Phase 1
- A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal CancerStatus unknownNCT02453464Phase 1
- Study of Compound Edaravone Injection for Treatment of Acute Ischemic StrokeCompletedNCT02430350Phase 3
- The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.Status unknownNCT02283476Phase 3
- Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid ArthritisStatus unknownNCT02275299Phase 4
- Fluorouracil Implants Used for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastric Cancer.Status unknownNCT02269904Phase 2
- Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell CarcinomaCompletedNCT02088515Phase 4
- Phase I Clinical Study of Metatinib Tromethamine TabletCompletedNCT02004548Phase 1
- Compound Edaravone Injection for Acute Ischemic StrokeCompletedNCT01929096Phase 2
- The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic ChemotherapyCompletedNCT01909856Phase 2
- Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRIStatus unknownNCT01893151Phase 4
- A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid TumorsStatus unknownNCT01847118Phase 1
- Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLCStatus unknownNCT01772732Phase 1
- A Study of Iguratimod in Patients With Active Rheumatoid ArthritisCompletedNCT01554917Phase 4
- Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid ArthritisStatus unknownNCT01548001Phase 4
- A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer PatientsCompletedNCT01531790Phase 1
- Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of Simotinib Hydrochloride in Healthy SubjectsCompletedNCT01469910Phase 1
- Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in ChinaCompletedNCT01459081Phase 3
- Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain MetastasesStatus unknownNCT01410370Phase 2
- Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer PatientsStatus unknownNCT01368419Phase 2
- Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or AscitesCompletedNCT01327235Phase 2
- Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential HypertensionCompletedNCT01131546Phase 4
- Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic LeukemiaCompletedNCT01109264Phase 2
- A Study of Endostar Combined With Chemotherapy for Treatment of OsteosarcomaStatus unknownNCT01002092Phase 2
- Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)CompletedNCT00912392Phase 2
- Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00708812Phase 2
← Simcere Pharmaceutical Group Limited overview and focus areas